Meetings - The ASCO Post

This is Part 3 of Evolving Treatment Paradigms for Neuroendocrine Tumors, a three-part video roundtable series. Scroll down to watch the other videos from this roundtable. In this video, Drs. Daniel...

neuroendocrine tumors

gastrointestinal cancer

/ Evolving Treatment Paradigms for Neuroendocrine Tumors

Case 2: Well-Differentiated Grade 3 Small Bowel Neuroendocrine Tumor

This is Part 2 of Evolving Treatment Paradigms for Neuroendocrine Tumors, a three-part video roundtable series. Scroll down to watch the other videos from this roundtable. In this video, Drs. Daniel...

gastrointestinal cancer

neuroendocrine tumors

pancreatic cancer

/ Evolving Treatment Paradigms for Neuroendocrine Tumors

Case 1: Pancreatic Neuroendocrine Tumor

This is Part 1 of Evolving Treatment Paradigms for Neuroendocrine Tumors, a three-part video roundtable series. Scroll down to watch the other videos from this roundtable. In this video, Drs. Danie...

Evolving Treatment Paradigms for Neuroendocrine Tumors

Case 3: Radioligands in Advanced Neuroendocrine Tumor

Case 2: Well-Differentiated Grade 3 Small Bowel Neuroendocrine Tumor

Case 1: Pancreatic Neuroendocrine Tumor

FDA Amends Pembrolizumab’s Gastric Cancer Indication

Investigational Dual PD-1 and TIGIT Blockade in Advanced Gastroesophageal Cancer

Perioperative Pembrolizumab Plus Chemotherapy in Locally Advanced Gastric/Gastroesophageal Cancer

Additional Analysis of MATTERHORN Confirms Global Benefit of Durvalumab Plus FLOT in Gastric/Gastroesophageal Cancer

Fruquintinib Plus Paclitaxel as Second-Line Treatment for Gastric or Gastroesophageal Junction Cancer